| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,308,459 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,419,819 |
|
|
|
Indirect Value
|
$12,547,761 |
|
|
| Total
Shares |
17,983,225 |
|
|
| Total
Value |
$45,967,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
8
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -725.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-17 |
1,129,996 |
2024-05-17 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-04-22 |
4 |
S |
$0.75 |
$1,393 |
D/D |
(1,857) |
1,138,096 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-05 |
4 |
S |
$141.79 |
$280,404 |
D/D |
(1,954) |
175,752 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-10 |
4 |
S |
$171.15 |
$339,733 |
D/D |
(1,985) |
162,708 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2008-09-22 |
4 |
S |
$41.37 |
$85,429 |
D/D |
(2,065) |
60,233 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-03-16 |
4 |
S |
$34.25 |
$80,727 |
D/D |
(2,357) |
63,840 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2023-11-17 |
4 |
S |
$1.63 |
$4,061 |
D/D |
(2,490) |
1,167,749 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-04 |
4 |
S |
$153.63 |
$414,801 |
D/D |
(2,700) |
129,775 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2015-02-09 |
4 |
S |
$174.18 |
$470,810 |
D/D |
(2,703) |
164,693 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-11 |
4 |
S |
$47.68 |
$136,412 |
D/D |
(2,861) |
46,846 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-02-20 |
4 |
S |
$0.70 |
$2,011 |
D/D |
(2,893) |
1,142,359 |
0 |
% |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2023-07-05 |
4 |
S |
$3.05 |
$9,084 |
D/D |
(2,983) |
1,186,852 |
0 |
% |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-05-17 |
4 |
S |
$0.75 |
$2,355 |
D/D |
(3,143) |
1,129,996 |
0 |
% |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-01-23 |
4 |
S |
$0.67 |
$2,150 |
D/D |
(3,205) |
1,163,583 |
0 |
% |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-02-04 |
4 |
S |
$95.61 |
$333,692 |
D/D |
(3,483) |
308,155 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,706 |
27,706 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2016-02-08 |
4 |
S |
$132.02 |
$535,316 |
D/D |
(3,890) |
171,862 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$20.72 |
$82,880 |
D/D |
4,000 |
24,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-09-29 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
69,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-11-22 |
4 |
OE |
$16.35 |
$65,400 |
D/D |
4,000 |
77,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
164,295 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• • – |
2007-09-24 |
4 |
AS |
$63.00 |
$263,032 |
D/D |
(4,162) |
28,544 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
33,044 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & CFO |
• – – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
312,655 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2011-05-25 |
4 |
A |
$11.92 |
$53,688 |
D/D |
4,504 |
177,464 |
0 |
- |
|
| ALVR |
Allovir Inc |
See Remarks |
• • • |
2024-05-03 |
4 |
S |
$0.80 |
$3,946 |
D/D |
(4,957) |
1,133,139 |
0 |
% |
|
145 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
